Hep C Drugs Cost FL Medicaid $30M So Far

Hep C Drugs Cost FL Medicaid $30M So Far

Florida Medicaid has spent at least $30.6 million in the past year on costly drug treatments for Hepatitis C, according to records from the Agency for Health Care Administration.

Most of the spending was for Sovaldi, an antiviral approved by the Food and Drug Administration in December 2013. It was fast-tracked after clinical trials showed it had a high cure rate for patients in advanced stages of liver disease who were infected with the most common strain of the Hepatitis C virus.

According to information provided by AHCA, Florida Medicaid approved $26.4 million in Sovaldi treatment for 333 fee-for-service patients between the time Sovaldi was approved and October 27.

Read more at http://bit.ly/1AiSbcg